ArticleDrug design, development and therapy2026

Temporal Alignment and Validation in Machine-Learning Prediction of Secondary Loss of Response to Infliximab [Letter].

Zeming Qiu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.